Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient
{{output}}
Euglycemic diabetic ketoacidosis (euDKA) is a rare but deadly complication of sodium-glucose cotransport-2 (SGLT-2) inhibitors. Primarily indicated for the treatment of Type 2 Diabetes Mellitus, the incidence of euDKA is expected to rise as SGLT-2 inhibitors b... ...
